EP. 210: In this episode, I’m covering the groundbreaking new data showing a jaw-dropping 45% reduction in dementia risk—and no, it’s not from a new Alzheimer’s drug or expensive intervention. It's from good old GLP-1 medications. I'm walking you through the data, the mechanisms, and what this could mean for your future health.
Topics Discussed:
-
Recent study: Can GLP-1 medications reduce the risk of dementia?
-
What are the neurocognitive benefits of GLP-1 peptides?
-
Are GLP-1 receptor agonists effective for brain health and memory protection?
-
How do GLP-1s work to prevent cognitive decline or Alzheimer's disease? What does the data show?
On This Episode We Cover:
-
00:00:00 – Introduction
-
00:03:49 – Neurocognitive benefits of GLP-1s
-
00:07:35 – Other benefits of GLP-1s
-
00:13:33 – Biomechanisms of GLP-1s
-
00:15:06 – Alternative options and final thoughts
Show Links:
Further LIstening
Sponsored By:
Disclaimer: Information provided in this podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional, or any information contained on or in any product. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal or other supplement, or using any treatment for a health problem. Information provided in this blog/podcast and the use of any products or services related to this podcast by you does not create a doctor-patient relationship between you and Dr. Tyna Moore. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease.
